AUPH
Aurinia Pharmaceuticals Inc
15.70$
-0.2%
vs. previous close
Closing price · As of: Oct 6, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -24.4% | 31.7% | -37.0% | 27.7% | 25.1% | 50.3% | 2.1% | 63.2% | 60.5% | 57.8% | 41.9% | 62.7% | 55.8% | |
| 9.7% | 11.0% | 9.6% | 8.5% | 7.2% | 8.1% | 7.8% | 6.9% | 6.6% | 6.3% | 3.2% | 5.8% | 5.5% | |
| 21.7% | 26.1% | 11.4% | 15.0% | 12.3% | 14.9% | -5.5% | 7.8% | 8.1% | 8.7% | -1.1% | 3.4% | 4.7% | |
| -25.5% | 43.1% | -21.4% | 9.0% | -16.8% | 37.5% | -40.0% | 8.2% | 5.4% | 8.7% | -16.6% | 1.8% | -0.2% | |
| 0.2% | 0.1% | 0.0% | 0.2% | 0.1% | 0.1% | 0.0% | 0.1% | 0.1% | 0.1% | 0.1% | 0.0% | 0.1% | |
| -36.1% | -13.9% | 97.9% | -67.5% | -15.6% | 65.5% | 49.7% | -19.0% | -18.7% | -47.8% | -23.3% | 97.5% | 4.0% | |
| 0.0% | – | -24.5% | -10.7% | -0.2% | -36.4% | -75.1% | -60.8% | -12.3% | 1.7% | -46.5% | -46.1% | -26.4% | |
| – | – | – | – | -4.4% | -5.1% | -4.4% | -4.9% | -4.7% | -4.5% | -4.7% | -4.1% | -4.5% | |
| -4.3% | -12.4% | -29.9% | -14.5% | -4.0% | -38.5% | -79.0% | -63.4% | -14.3% | -0.7% | -69.1% | 6.1% | -19.1% | |
| -64.8% | 5.5% | 31.0% | -54.3% | 5.5% | 77.3% | -27.2% | -19.2% | 27.5% | 9.1% | -50.5% | 166.8% | 40.7% | |
| -24.2% | 31.6% | -37.0% | 27.5% | 25.0% | 50.2% | 2.1% | 63.1% | 60.4% | 57.7% | 41.9% | 62.7% | 55.7% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.